Day One Biopharmaceuticals Inc

Stock Chart, Company Information, and Scan Results

$8.38(as of Nov 19, 3:58 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Day One Biopharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$8.38
Ticker SymbolDAWN
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees184
CountyUSA
Market Cap$879.9M

Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.

Day One Biopharmaceuticals Inc In Our Stock Scanner

As of Nov 20, 2025
As of ---
As of ---
example chart graphic
Scan Name: Golden CrossScan Type: Stock Indicator Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.